<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221109056454N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-21</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Evaluating the effect of celecoxib in comparison with acetaminophen on orthodontic pain management</public_title>
      <acronym></acronym>
      <scientific_title>Evaluating the effect of celecoxib in comparison with acetaminophen on pain management after insertion of first orthodontic wire: a randomized, double-blind, controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66887</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization of patients into two groups under study will be done by permutation block method with size 2x35. The list of random numbers will be prepared by the thesis statistics advisor and will be provided to pharmacist. The website https://www.sealedenvelope.com will be used to generate the list of random numbers. In order to conceal the allocation, the drugs (Celecoxib and Acetaminophen) with the same weight, appearance, color are prepared in identically packaged containers and are coded according to a list of random numbers and assigned to each patient who enters the study sequentially. is allocated and the drug container receives the corresponding code, Blinding description: This study will be double-blind and the statistician will be blind and does not know about the groups under study. Also, the patient will be blind and does not know what medicine he is taking. But in this study, there is no need to blind the dentist because he has no role in evaluating and measuring the outcome of the study and it is the patient who self-reports using the VAS index to measure pain at the considered times. Because in this study and in general, in the placement of orthodontic wire, the same brand of wire (which is American Orthodontics (AO)) is an important issue, and the performance of the clinician in this case will not be influential or confusing.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pain after placing the first orthodontic wire.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The group that was prescribed celecoxib 200 mg 1 hour before and 6 hours after receiving the orthodontic wire. Intervention 2: Intervention group: The group that was prescribed 500 mg of acetaminophen 1 hour before and 6 hours after receiving the orthodontic wire.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All non-personally identifiable information

When:
6 months after the results are published

To whom:
Researchers in academic and scientific institutions

Conditions:
In order to familiarize with the type of study for similar studies and judging

Where to obtain:
Project manager, Dr. Atefeh Safar Shahroudi
a-shahroudi@tums.ac.ir

How to obtain:
Details of the requesting person and the relevant organization, the reason for the request and the process to be carried out

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Atefeh Saffar Shahroudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dr. Shahroudi's office, 1st floor, unit 2, Afra Building, , Itsar St., corner of Mehr Alley, Marzdaran Blvd.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1464643114</zip>
        <telephone>+98 21 4426 9453</telephone>
        <email>a-shahroudi@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Atefeh Saffar Shahroudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dr. Shahroudi's office, 1st floor, unit 2, Afra Building, , Itsar St., corner of Mehr Alley, Marzdaran Blvd.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1464643114</zip>
        <telephone>+98 21 4426 9453</telephone>
        <email>a-shahroudi@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patient's age is between 12 and 30 years
The treatment plan for orthodontic patients should be fixed without tooth extraction.
According to little's irregularity index, they should have a moderate rating.
Orthodontic treatment should start with the lower jaw.</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>30 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Taking antibiotics and painkillers before orthodontic treatment
Pregnant and lactating women
Patients with history of allergy to celecoxib or acetaminophen
Patients with a history of gastrointestinal or kidney ulcer and liver or cardiovascular failure
History of drug addiction
Not having written informed consent to participate in the study
Patients with periodontal disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z46.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Encounter for fitting and adjustment of orthodontic device</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The group that was prescribed celecoxib 200 mg 1 hour before and 6 hours after receiving the orthodontic wire.</i_keyword>
      <i_keyword>Intervention group: The group that was prescribed 500 mg of acetaminophen 1 hour before and 6 hours after receiving the orthodontic wire.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Overall pain score. Timepoint: 2 hours after wire placement, 6 hours after that, the first night of wire placement, 24 hours after the start, and finally on the second, third, and seventh day. Method of measurement: The patient's score on the severity of orthodontic pain in the general state with the VAS index.</prim_outcome>
      <prim_outcome>Pain score in chewing mode. Timepoint: 2 hours after wire placement, 6 hours after that, the first night of wire placement, 24 hours after the start, and finally on the second, third, and seventh day. Method of measurement: Patient's score of orthodontic pain severity in chewing state with VAS index.</prim_outcome>
      <prim_outcome>Pain score in biting position. Timepoint: 2 hours after wire placement, 6 hours after that, the first night of wire placement, 24 hours after the start, and finally on the second, third, and seventh day. Method of measurement: Patient score of orthodontic pain severity in biting state with VAS index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>personal</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-21</approval_date>
        <contact_name>Research Ethics Committees of School of Dentistry- Tehran University of Medical Sciences</contact_name>
        <contact_address>Tehran- Quds town (west)- between South Flamak and Zarafshan, Simai Iran street- Central headquarters of the Ministry of Health, Treatment and Medical Education, block A, 13th floor Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
